Global Hemodynamic Monitoring System Market, 2015 to 2021

Global Hemodynamic Monitoring System Market, 2015 to 2021
Persistence Market Research
Global Hemodynamic Monitoring Systems
Market Poised to Account for US$ 508.4 Mn
by the End of 2021: Persistence Market
Research
Persistence Market Research 1

Global Hemodynamic Monitoring System Market, 2015 to 2021
Persistence Market Research Released New Market Report According to a new market report
published by Persistence Market Research “Global Market Study on Hemodynamic
Monitoring System: Growing Demand for Critical Congenital Heart Disease
Screening to Drive the Market by 2021 ”, projected the hemodynamic monitoring
systems market to expand at a healthy CAGR of 6.5% during the forecast period. The report
offered trends driving the market and delivered analysis and insights on the potential of the
hemodynamic monitoring systems market in specific regions.
In terms of revenue, the hemodynamic monitoring systems market was valued at US$ 328.7
Mn in 2014 and is projected to reach US$ 508.4 Mn by 2021. Factors driving market growth
include government and private sector initiatives to reduce healthcare costs, rising
prevalence of lifestyle diseases, growing the geriatric patient population, increasing the
incidence of respiratory disorders and growing demand for the screening of critical
congenital heart disease (CCHD).
Request Sample Report: http://www.persistencemarketresearch.com/samples/4396
In terms of region, North America dominated the hemodynamic monitoring systems market
with over 30% share in terms of value in 2014 but is expected to lose its market share to
APAC by 2021. Europe accounted for over 20% of the total hemodynamic monitoring
systems market share in 2014 and will maintain its dominance through 2021. Among the
regions, APAC is projected to register the highest CAGR over 2015–2021 due to low-cost
product offerings by manufacturers in the region. As of 2014, APAC was the third-highest
contributor to the overall hemodynamic monitoring systems market, accounting for over
18% market share. By the end of 2021, it is projected to gain 330 BPS.
On the basis of device type, the market has been segmented into pulse contour,
oesophageal Doppler, volume clamp, hemodynamic monitoring sensors and pulmonary
artery catheters.
The pulmonary artery catheters segment had a dominant share in the global hemodynamic
monitoring systems market in 2014, while the volume clamp segment accounted for over
20% share.
Persistence Market Research 2

Global Hemodynamic Monitoring System Market, 2015 to 2021
Global hemodynamic monitoring systems market is further segmented on the basis of end
use into hospitals, clinics, ambulatory surgery centres, home care settings and independent
catheterisation laboratories. Revenue contribution of the hospitals segment was over 40% in
2014 and is projected to increase to over 42% by 2021, registering a significant CAGR of
7.3%. Home care settings segment is anticipated to record highest CAGR during the forecast
period as hemodynamic monitoring systems are being adopted increasingly in home care
settings.
By application type, the hemodynamic monitoring systems market is segmented into
invasive hemodynamic monitoring, noninvasive hemodynamic monitoring and minimally
invasive hemodynamic monitoring segments. Among the three segments, minimally
invasive hemodynamic monitoring segment is expected to register the highest CAGR of
8.0% over 2015-2021. The invasive hemodynamic monitoring segment accounted for over
30% market share in 2014 but is projected to lose its share to the other two segments by the
end of the forecast period.
View Detail Report With TOC: http://www.persistencemarketresearch.com/marketresearch/hemodynamic-monitoring-system-market.asp
Key players in the global hemodynamic monitoring systems market include Edwards
Lifesciences Corporation, ICU Medical, Inc., Teleflex Incorporated, LiDCO Group Plc and
PULSION Medical Systems SE. Global players focus on research and development initiatives
for introducing innovative products to attain sustainable advantages over their competitors.
In addition, they also focus on expanding their regional presence through mergers and
acquisitions. In developed regions, hemodynamic monitoring systems manufacturers prefer
selling their products directly to the consumer. By contrast, most vendors in countries such
as China have tie-ups with suppliers to enhance their customer reach. Globally, medical
equipment manufacturers in China account for over 50% market share for exporting
noninvasive devices.
Request Customized TOC: http://www.persistencemarketresearch.com/toc/4396
Persistence Market Research 3

Global Hemodynamic Monitoring System Market, 2015 to 2021
Market History:
The hemodynamic monitoring system is primarily used for clinical inspection of
cardiovascular health, longevity and quality of life of patients undergoing and recovering
from cardiac surgery. These parameters are measured using photometric, electrical,
pressure transducing equipment and invasive and noninvasive devices. The hemodynamic
monitoring system also involves a use of various intravascular catheters.
Some factors boosting the demand for hemodynamic monitoring systems are rising
prevalence of lifestyle diseases, increasing the incidence of respiratory disorders, growing
demand for the screening of critical congenital heart disease (CCHD), government and
private sector initiatives to reduce healthcare costs as well as growing geriatric patient
population.
CCHD, one of the seven most severe congenital heart defects, can be life threatening to
neonates. Asthma and chronic obstructive pulmonary diseases are among the most common
respiratory diseases. More than nine-tenths of deaths in low- and middle-income countries
occur due to chronic obstructive pulmonary diseases.
The global hemodynamic monitoring systems market is anticipated to register significant
CAGR during the forecast period. PMR projects the global hemodynamic monitoring systems
market to account for US$ 508.4 Mn by the end of 2021. Hemodynamic monitoring systems
market is expected to gain traction in developing regions such as APAC and Latin America.
The global hemodynamic monitoring systems market has been segmented into devices
based on technologies and methods such as pulse contour, oesophageal doppler, volume
clamp, hemodynamic monitoring sensors and pulmonary artery catheters.
The pulmonary artery catheters segment is estimated to dominate the global hemodynamic
monitoring systems market with 35.0% share by 2015 end, followed by volume clamp
segment. Increasing concerns regarding use of invasive techniques, particularly pulmonary
artery catheter for measuring cardiac output, have paved way for alternative methods for
measuring hemodynamic variables. Cardiac surgeons are increasingly seeking less invasive
Persistence Market Research 4

Global Hemodynamic Monitoring System Market, 2015 to 2021
approaches to aortic or mitral valve surgery. Key players are offering various systems that
enable minimal incision valve surgery.
By application, the global hemodynamic monitoring systems market has been segmented
into invasive hemodynamic monitoring, non-invasive hemodynamic monitoring and
minimally invasive hemodynamic monitoring.
The invasive hemodynamic monitoring segment is projected to lose its dominance
throughout the forecast period. Noninvasive hemodynamic monitoring application segment
is projected to gain BPS during the forecast period. Among the three application segments,
minimally invasive hemodynamic monitoring segment is anticipated to record the highest
CAGR by the end of the forecast period.
By end-use, the hemodynamic monitoring systems market is segmented into home care
settings, ambulatory surgery centres, hospitals, clinics and independent catheterisation
laboratories. Hospitals segment is projected to exhibit above-average growth during the
forecast period.
The global hemodynamic monitoring systems market has been segmented into five regions:
North America, Latin America, Europe, APAC and Middle East & Africa. North America region
was the largest market in terms of revenue contribution, accounting for 30.5% share of the
overall hemodynamic monitoring systems market in 2014. This is attributed to the
increasing number of cancer and cardiovascular patients, especially in the U.S. Europe
region is projected to lose 40 BPS during the forecast period. Among the five regions, APAC
region is projected to expand at the highest CAGR during the forecast period.
Some key players included in the report are Edwards Lifesciences Corporation, ICU Medical,
Inc., Teleflex Incorporated, LiDCO Group Plc and PULSION Medical Systems SE. Global players
are investing on R&D to introduce innovative products in order to gain competitive edge.
Additionally, they are also focusing on regional expansion through mergers and acquisitions.
In developed regions, hemodynamic monitoring systems manufacturers prefer selling their
products directly to consumer. By contrast, most vendors in countries such as China have
tie-ups with suppliers to enhance their customer reach. Globally, medical equipment
Persistence Market Research 5

Global Hemodynamic Monitoring System Market, 2015 to 2021
manufacturers in China account for over 50% market share for exporting noninvasive
devices.
About Us:
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated
research, custom research, and consulting services. PMR boasts market research expertise across the
Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages,
Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The
company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data
that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
Persistence Market Research 6